Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy NanoViricides stock

Learn how to easily invest in NanoViricides stock.

NanoViricides Inc is a biotechnology business based in the US. NanoViricides shares (NNVC) are listed on the NYSE MKT and all prices are listed in US Dollars. NanoViricides employs 17 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in NanoViricides

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NNVC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

NanoViricides stock price (NYSE MKT: NNVC)

Use our graph to track the performance of NNVC stocks over time.

NanoViricides shares at a glance

Information last updated 2022-01-24.
Latest market close$2.25
52-week range$1.99 - $8.71
50-day moving average $3.97
200-day moving average $4.16
Wall St. target price$8.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.82

Buy NanoViricides shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NanoViricides stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NanoViricides price performance over time

Historical closes compared with the close of $2.25 from 2022-01-24

1 week (2022-01-19) -16.04%
1 month (2021-12-23) -42.89%
3 months (2021-10-26) -54.08%
6 months (2021-07-26) -46.30%
1 year (2021-01-26) -46.04%
2 years (2020-01-24) -73.37%
3 years (2019-01-25) 690.58%
5 years (2017-01-26) 99.12%

NanoViricides financials

Gross profit TTM $0
Return on assets TTM -18.61%
Return on equity TTM -31.31%
Profit margin 0%
Book value $2.46
Market capitalisation $25.9 million

TTM: trailing 12 months

NanoViricides share dividends

We're not expecting NanoViricides to pay a dividend over the next 12 months.

Have NanoViricides's shares ever split?

NanoViricides's shares were split on a 1:20 basis on 23 September 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NanoViricides shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for NanoViricides shares which in turn could have impacted NanoViricides's share price.

NanoViricides share price volatility

Over the last 12 months, NanoViricides's shares have ranged in value from as little as $1.99 up to $8.71. A popular way to gauge a stock's volatility is its "beta".

NNVC.US volatility(beta: 0.59)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NanoViricides's is 0.5905. This would suggest that NanoViricides's shares are less volatile than average (for this exchange).

NanoViricides overview

NanoViricides, Inc. , a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut. .

Frequently asked questions

What percentage of NanoViricides is owned by insiders or institutions?
Currently 5.173% of NanoViricides shares are held by insiders and 8.275% by institutions.
How many people work for NanoViricides?
Latest data suggests 17 work at NanoViricides.
When does the fiscal year end for NanoViricides?
NanoViricides's fiscal year ends in June.
Where is NanoViricides based?
NanoViricides's address is: 1 Controls Drive, Shelton, CT, United States, 06484
What is NanoViricides's ISIN number?
NanoViricides's international securities identification number is: US6300873022
What is NanoViricides's CUSIP number?
NanoViricides's Committee on Uniform Securities Identification Procedures number is: 630087104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site